カリフォルニア州における動脈硬化の臨床試験
カリフォルニア州内の拠点で、動脈硬化に関する14件の研究が参加者を募集しています。
カリフォルニア州内の都市
- San Diego6件の研究
- Santa Monica6件の研究
- Los Angeles6件の研究
- Torrance5件の研究
- Mountain View4件の研究
- West Covina4件の研究
- Simi Valley4件の研究
- San Francisco3件の研究
- South Gate3件の研究
- Santa Clarita3件の研究
公式研究テキスト（英語）
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Thrive Clinical Research Group, Glendora
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- Cardiovascular Research Foundation of Southern California, Beverly Hills
- National Heart Institute, Beverly Hills
- Amnova Clinical Research, Irvine
- 他3件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- National Heart Institute, Beverly Hills
- John Muir Medical Center - Concord Campus, Concord
- Neighborhood Healthcare Institute of Health, Escondido
- 他9件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Valley Clinical Trials, LLC dba Flourish Research, Covina
- Velocity Clinical Research- Huntington Park, Huntington Park
- Orange County Research Center, Lake Forest
- 他5件
被験者募集中第3相
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- Thrive Clinical Research Group, LLC, Covina
- Clinical Trials Research, Lincoln
- University of California Irvine Medical Center - Cardiovascular Center, Los Alamitos
- 他2件
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07521007A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla
- Valley Clinical Trials, Inc., Northridge
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
被験者募集中第3相
45歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07613294Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- National Institute of Clinical Research, Bakersfield
- California Institute of Renal Research, Chula Vista
- The Medical Research Group, Inc., Fresno
- 他27件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Beverly Hills
- Research Site, Canoga Park
- Research Site, Castroville
- 他26件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/24更新 · NCT07000357Pelacarsen Roll-over Extension Program
- National Heart Institute, Beverly Hills
- Hope Clinical Research, Canoga Park
- University of Calif Irvine Med Cntr, Irvine
- 他3件
被験者募集中第3相
18歳〜100歳 · 全性別 · 2026/07/29更新 · NCT06875973Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History
- Keck School of Medicine, University of Southern California, Los Angeles
被験者募集中
65歳〜84歳 · 全性別 · 2026/06/08更新 · NCT05867381Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- VA Loma Linda Healthcare System, Loma Linda, CA, Loma Linda
- VA Long Beach Healthcare System, Long Beach, CA, Long Beach
- VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto
- 他2件
被験者募集中第4相
18歳以上 · 全性別 · 2025/12/17更新 · NCT02915198Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
- UCLA Center for Clinical AIDS Research and Education (CARE), Los Angeles
- San Francisco General Hospital, San Francisco
被験者募集中第2相
40歳以上 · 全性別 · 2025/12/17更新 · NCT05488431Text Education About Cardiovascular Health and HIV (TEACH-HIV)
- Zuckerberg San Francisco General Hospital, San Francisco
- University of California San Francisco, San Francisco
被験者募集中
40歳以上 · 全性別 · 2025/06/08更新 · NCT05642858Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
- Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center (The Lundquist Institute), Torrance
被験者募集中第4相
40歳〜80歳 · 全性別 · 2024/10/15更新 · NCT05708859ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。